Harry J Leonhardt insider trades

Open-market stock purchases and sales by Harry J Leonhardt, GC & Chief Compliance Officer at Poseida Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2011.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • PSTX Poseida Therapeutics, Inc: other filings, last Jan 8, 2025
  • HALO Halozyme Therapeutics Inc: other filings, last Apr 13, 2019
  • AMLN Amylin Pharmaceuticals Inc: 2 sales, last Aug 8, 2012

Get free alerts when Harry J Leonhardt files a new trade →